title: Protean phenotypic features of the A3243G mitochondrial DNA mutation.
abstract: OBJECTIVE
  To describe the spectrum of clinical symptoms, signs, and laboratory features associated with A3243G, a mitochondrial DNA point mutation that affects multiple organs with varying severity, making the diagnosis and treatment of these patients complex.
  
  
  METHODS
  Cohort study.
  
  
  METHODS
  Columbia University Medical Center.
  
  
  METHODS
  A cohort of 123 matrilineal relatives from 45 families, including 45 fully symptomatic patients with mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes (syndrome), 78 carrier relatives, and 30 controls.
  
  
  METHODS
  Data gathered from standardized medical history questionnaires, neurological and ophthalmological examination forms, and laboratory tests. We compared data between 3 groups.
  
  
  RESULTS
  Mutation carriers' clinical and laboratory results frequently had many abnormalities. In addition to neurological symptoms, they often had cardiac, endocrine, gastrointestinal, and psychiatric symptoms.
  
  
  CONCLUSIONS
  The A3243G mutation carriers have multiple medical problems, suggesting that the A3243G mutation should be considered as an etiological factor in patients with multisystem clinical presentations or a family history compatible with matrilineal inheritance. Because some medical problems affecting A3243G mutation carriers are treatable, early detection and proactive management may mitigate the burden of morbidity.
authors.affiliation: Department of Neurology, The Neurological Institute, Columbia University Medical Center, New York, NY 10032, USA. pk88@columbia.edu
authors.forename: Petra
authors.initials: P
authors.lastname: Kaufmann
authors.forename: Kristin
authors.initials: K
authors.lastname: Engelstad
authors.forename: Ying
authors.initials: Y
authors.lastname: Wei
authors.forename: Romana
authors.initials: R
authors.lastname: Kulikova
authors.forename: Maryam
authors.initials: M
authors.lastname: Oskoui
authors.forename: Vanessa
authors.initials: V
authors.lastname: Battista
authors.forename: Dorcas Y
authors.initials: DY
authors.lastname: Koenigsberger
authors.forename: Juan M
authors.initials: JM
authors.lastname: Pascual
authors.forename: Mary
authors.initials: M
authors.lastname: Sano
authors.forename: Michio
authors.initials: M
authors.lastname: Hirano
authors.forename: Salvatore
authors.initials: S
authors.lastname: DiMauro
authors.forename: Dikoma C
authors.initials: DC
authors.lastname: Shungu
authors.forename: Xiangling
authors.initials: X
authors.lastname: Mao
authors.forename: Darryl C
authors.initials: DC
authors.lastname: De Vivo
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D004272:DNA, Mitochondrial / Q000737:chemistry*; D042241:Early Diagnosis; D005260:Female; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D040582:Inheritance Patterns; D017241:MELAS Syndrome / Q000175:diagnosis* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D004272:DNA, Mitochondrial